A carregar...
Clinical efficacy of dupilumab in the treatment of severe chronic rhinosinusitis: The first case outside of a clinical trial
Treatment options for severe CRSwNP are limited. Dupilumab is a safe, well‐tolerated, and effective alternative in patients with poor control of symptoms, corticosteroid‐dependent disease, and high rates of recurrence of nasal polyps after surgery.
Na minha lista:
| Publicado no: | Clin Case Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7981721/ https://ncbi.nlm.nih.gov/pubmed/33768860 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ccr3.3792 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|